UPDATE : Tuesday, August 22, 2017
상단여백
Dong-A ST, Rooyan Darou sign business alliance for biologics
Dong-A ST struck a strategic business alliance with Iranian pharmaceutical ...
by Marian Chu  |  2017-08-22 16:07
라인
‘Hospital druggists are guardians protecting patients from medication error’
So many hospitals are offering multidisciplinary treatments that it has lon...
by Lee Hye-seon  |  2017-08-22 15:09
라인
2 immuno-oncology therapies receive insurance coverage
Two cancer immunotherapies -- Keytruda Inj. (pembrolizumab) and Opdivo Inj....
by Kwak Sung-sun  |  2017-08-21 15:03
라인
Amgen’s extended trial for osteoporosis treatment brings good results
Amgen Korea said Monday an extended clinical trial for its osteoporosis tre...
by Marian Chu  |  2017-08-21 14:49
라인
Boryung to improve antihypertensive drug
The Ministry of Food and Drug Safety Thursday approved Boryung Pharmaceutic...
by Marian Chu  |  2017-08-18 16:33
라인
Samyang develops multiple myeloma tablets for elderly
Samyang Biopharmaceuticals has developed Lenalidomide, a therapeutic agent ...
by Constance Williams  |  2017-08-18 12:02
라인
Pfizer gets FDA nod for lymphoid leukemia drug
The U.S. Food and Drug Administration (FDA) Thursday approved Besponsa (com...
by Constance Williams  |  2017-08-18 10:25
라인
27 ‘innovative’ drugmakers spend ₩588 billion on R&D
Twenty-seven “innovative” drugmakers invested 588.2 billion won ($517.7 mil...
by Lee Hye-seon  |  2017-08-17 16:31
라인
Takeda Korea unveils drug for ulcerative colitis, Crohn’s disease
Takeda Korea한국다케다제약 released its new drug Kynteles (compound: vedolizumab),...
by Constance Williams  |  2017-08-17 15:42
라인
SillaJen, US National Cancer Institute to conduct trials for Pexa-Vec
SillaJen신라젠 has signed a cooperative research and development agreement wit...
by Marian Chu  |  2017-08-17 15:11
라인
BMS at crossroads with mixed Opdivo-Yervoy trial results
Bristol-Myers Squibb (NYSE: BMY) announced Tuesday mixed results from its O...
by Marian Chu  |  2017-08-17 11:24
라인
Pfizer criticized for steep price hikes in global markets
Pfizer has come under fire in many countries for hiking up drug prices, and...
by Marian Chu  |  2017-08-17 08:53
라인
Amgen Korea releases high-cholesterol treatment
Amgen Korea암젠코리아 has released Repatha (component: evolocumab), a treatment ...
by Constance Williams  |  2017-08-16 17:19
라인
Drug industry’s market value showed mixed results
The aggregate market value of pharmaceutical industry increased more than 9...
by Nam Doo-hyun  |  2017-08-16 17:10
라인
Patent expiry of Lyrica, Tamiflu heats up generic market
The patents of painkiller Lyrica and influenza therapy Tamiflu with annual ...
by Lee Hye-seon  |  2017-08-16 16:36
라인
Daewoong launches Lyrica’s generic for neuropathic pain
Daewoong Pharmaceutical대웅제약 (CEO: Lee Jong-wook이종욱) has released a neuropat...
by Marian Chu  |  2017-08-16 10:30
라인
Green Cross steps up localization of tuberculosis vaccine
Green Cross has won the approval of phase 1 clinical trial plan of BCG vacc...
by Lee Hye-seon  |  2017-08-14 17:13
라인
Gilead’s hepatitis B therapy to vie with 20 Korean therapies
Korea has approved 20 products made by Korean companies targeting for No.1 ...
by Lee Hye-seon  |  2017-08-14 11:54
라인
4 Korean pharmaceuticals make waves in immunotherapy market
Korean pharmaceutical companies are catching up in the immunotherapy market...
by Marian Chu  |  2017-08-12 06:00
라인
Ministry designates 2 new orphan drugs
The Ministry of Food and Drug Safety designated Nusinersen and Tacrolimus a...
by Marian Chu  |  2017-08-11 16:55
여백
여백
여백
Back to Top